Healthcare Services

Diagnostic Biomarkers Market: Growth Opportunities Through 2030

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Diagnostic Biomarkers Market Between 2026 And 2030?

The diagnostic biomarkers market has experienced significant expansion in recent years. Projections indicate it will increase from $75.46 billion in 2025 to $87.47 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This historical expansion is largely due to factors such as advancements in molecular diagnostics, increased cancer research, the shortcomings of conventional diagnostic methods, the increasing prevalence of chronic diseases, and various biomarker validation studies.

The diagnostic biomarkers market is anticipated to experience substantial expansion over the next few years. It is projected to reach $155.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. This growth throughout the forecast period stems from factors such as advancements in omics technologies, the proliferation of personalized medicine, AI-driven biomarker discovery, regulatory approvals for new biomarkers, and an increasing demand for predictive diagnostics. Significant trends during this period include a heightened adoption of precision diagnostic biomarkers, a growing utilization of genomic and proteomic biomarkers, an expanded role for biomarkers in oncology diagnostics, the integration of biomarker data with clinical analytics, and an escalating need for early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/diagnostic-biomarkers-global-market-report

Which Key Drivers Are Affecting The Diagnostic Biomarkers Market Development?

The expanding occurrence of cancer is a key factor propelling the diagnostic biomarkers market forward. This rise in cancer cases is influenced by an aging global population, evolving lifestyle choices, increased environmental exposures, and advancements in diagnostic technologies. Diagnostic biomarkers are essential in managing cancer by facilitating early discovery, accurate identification, and customized treatment plans, thereby enhancing patient results. For example, in January 2024, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, showed a significant increase in cancer cases, reaching 2,001,140 from 1,958,310 in 2023, marking a 2.19% growth. This escalating incidence of cancer is consequently boosting the expansion of the diagnostic biomarkers market.

How Is The Diagnostic Biomarkers Market Broken Down By Segment Categories?

The diagnostic biomarkers market covered in this report is segmented –

1) By Product: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Application: Oncology, Metabolic Disease, Neurological Disease

3) By End User: Hospitals, Cancer Research Institutes, Diagnostic Labs

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Organ-Specific Safety Biomarkers, Drug-Induced Injury Biomarkers

2) By Efficacy Biomarkers: Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers

3) By Validation Biomarkers: Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers

What Trends Are Transforming The Diagnostic Biomarkers Market?

Leading companies within the diagnostic biomarkers market are prioritizing the development of non-invasive testing approaches, such as blood-based biomarker tests, to improve patient comfort and accessibility while supporting personalized treatment plans. A blood-based biomarker test serves as a diagnostic instrument that identifies or monitors diseases, including Alzheimer’s, by analyzing specific biological markers found in the blood in a minimally intrusive way. For instance, in July 2023, Quanterix Corporation, a US-based life sciences company, introduced LucentAD, a blood-based biomarker test designed to assist healthcare professionals in diagnosing Alzheimer’s disease (AD) in patients presenting with early cognitive symptoms. The test measures plasma levels of phosphorylated tau protein at the 181 residue (p-Tau 181), a biomarker linked to amyloid pathology in the brain and a crucial indicator of AD. By offering a less invasive and more accessible diagnostic option compared to traditional methods like cerebrospinal fluid analysis or amyloid positron emission tomography, LucentAD aims to streamline the evaluation process for individuals suspected of having Alzheimer’s.

Which Players Are Present In The Diagnostic Biomarkers Market Space?

Major companies operating in the diagnostic biomarkers market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS

Get The Full Diagnostic Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/diagnostic-biomarkers-global-market-report

Which Region Accounts For The Largest Portion Of The Diagnostic Biomarkers Market?

North America was the largest region in the diagnostic biomarkers market in 2025. The regions covered in the diagnostic biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diagnostic Biomarkers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/diagnostic-biomarkers-global-market-report

Browse Through More Reports Similar to the Global Diagnostic Biomarkers Market 2026, By The Business Research Company

Oncology Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795